Literature DB >> 34019299

Chromogenic In Situ Hybridization (CISH) as a Method for Detection of C-Myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue: An Update.

Nataša Todorović-Raković1.   

Abstract

In situ hybridization (ISH) allows evaluation of genetic abnormalities, such as changes in chromosome number, chromosome translocations, or gene amplifications, by hybridization of tagged DNA (or RNA) probes with complementary DNA (or RNA) sequences in interphase nuclei of target tissue. However, chromogenic in situ hybridization (CISH) is also applicable to formalin-fixed, paraffin-embedded (FFPE ) tissues, besides metaphase chromosome spreads. CISH is similar to fluorescent in situ hybridization (FISH) regarding pretreatments and hybridization protocols but differs in the way of visualization. Indeed, CISH signal detection is similar to that used in immunohistochemistry, making use of a peroxidase-based chromogenic reaction instead of fluorescent dyes. In particular, tagged DNA probes are indirectly detected using an enzyme-conjugated antibody targeting the tags. The enzymatic reaction of the chromogenic substrate leads to the formation of strong permanent brown signals that can be visualized by bright-field microscopy at 40× magnification. The advantage of CISH is that it allows the simultaneous observation of gene amplification and tissue morphology, and the slides can be stored for a long time.

Entities:  

Keywords:  Chromogenic in situ hybridization (CISH); c-myc amplification

Year:  2021        PMID: 34019299     DOI: 10.1007/978-1-0716-1476-1_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.

Authors:  L H Augenlicht; S Wadler; G Corner; C Richards; L Ryan; A S Multani; S Pathak; A Benson; D Haller; B G Heerdt
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  C-myc as a predictive marker for chemotherapy in metastatic breast cancer.

Authors:  Nataša Todorović-Raković; Zora Nešković-Konstantinović; Dragica Nikolić-Vukosavljević
Journal:  Clin Exp Med       Date:  2011-11-24       Impact factor: 3.984

Review 3.  The role of c-myc in cell growth.

Authors:  G I Evan; T D Littlewood
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

4.  Genomic determinants of somatic copy number alterations across human cancers.

Authors:  Yanping Zhang; Hongen Xu; Dmitrij Frishman
Journal:  Hum Mol Genet       Date:  2016-01-04       Impact factor: 6.150

5.  Emerging landscape of oncogenic signatures across human cancers.

Authors:  Giovanni Ciriello; Martin L Miller; Bülent Arman Aksoy; Yasin Senbabaoglu; Nikolaus Schultz; Chris Sander
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

6.  Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer.

Authors:  Malihea Khaleghian; Issa Jahanzad; Abbas Shakoori; Amirnader Emami Razavi; Cyrus Azimi
Journal:  Iran Red Crescent Med J       Date:  2016-01-01       Impact factor: 0.611

7.  Evaluating HER2 Gene Amplification Using Chromogenic In Situ Hybridization (CISH) Method In Comparison To Immunohistochemistry Method in Breast Carcinoma.

Authors:  Hadi Atabati; Amir Raoofi; Abdollah Amini; Reza Masteri Farahani
Journal:  Open Access Maced J Med Sci       Date:  2018-11-20

8.  Relationship Study of The Verified H uman Epidermal Growth Factor Receptor 2 Amplification with Other Tumor Markers and Clinicohistopathological Characteristics in Patients with Invasive Breast Cancer, Using Chromogenic In Situ Hybridization.

Authors:  Abdolazim Sarli; Hossein Mozdarani; Nasser Rakhshani; Sohail Mozdarani
Journal:  Cell J       Date:  2019-06-15       Impact factor: 2.479

9.  Chromogenic in Situ Hybridization Technique versus Immunohistochemistry in Assessment of HER2/neu Status in 448 Iraqi Patients with Invasive Breast Carcinoma.

Authors:  Ali Hussein Mohammed Ali; Alaa Qasim Yahya; Haider Latteef Mohammed
Journal:  Open Access Maced J Med Sci       Date:  2019-06-30

10.  Study of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods.

Authors:  Malihea Khaleghian; Issa Jahanzad; Abbas Shakoori; Farid Azmoudeh Ardalan; Cyrus Azimi
Journal:  Adv Biomed Res       Date:  2015-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.